CoChat

Intestinal microbiome is related to lifetime antibiotic use in Finnish pre-school children

Open access
Korpela, Katri, Salonen, Anne, Virta, Lauri J., Kekkonen, Riina A., Forslund, Kristoffer, Bork, Peer, de Vos, Willem M. · 2016 · Nature Communications

The DOI matches its Crossref record; 63 of the 64 references it cites were found in a registry or an index.

Abstract

Early-life antibiotic use is associated with increased risk for metabolic and immunological diseases, and mouse studies indicate a causal role of the disrupted microbiome. However, little is known about the impacts of antibiotics on the developing microbiome of children. Here we use phylogenetics, metagenomics and individual antibiotic purchase records to show that macrolide use in 2-7 year-old Finnish children (N=142; sampled at two time points) is associated with a long-lasting shift in microbiota composition and metabolism. The shift includes depletion of Actinobacteria, increase in Bacteroidetes and Proteobacteria, decrease in bile-salt hydrolase and increase in macrolide resistance. Furthermore, macrolide use in early life is associated with increased risk of asthma and predisposes to antibiotic-associated weight gain. Overweight and asthmatic children have distinct microbiota compositions. Penicillins leave a weaker mark on the microbiota than macrolides. Our results support the idea that, without compromising clinical practice, the impact on the intestinal microbiota should be considered when prescribing antibiotics.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/ncomms10410

Cites

63 of 63 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Microbiota composition in 257 fecal samples as arranged per group. C denotes control group, no antibiotics for the past 2 years and in total <1 course per year of life on average. E denotes early-life exposure group, no antibiotics for the past 2 years and >1 course per year of life on average. M6 denotes macrolide course within 6 months; M12 denotes macrolide course within 6–12 months; M24 denotes macrolide course within 12–24 months. P6, P12 and P24 denote penicillin courses within 6, 6–12 and 12–24 months, respectively. (a) Phyla composition. (b) Genus-level microbiota composition according to PCoA analysis. The background colour indicates interpolated time since the last macrolide course.
Figure 1 Microbiota composition in 257 fecal samples as arranged per group. C denotes control group, no antibiotics for the past 2 years and in total <1 course per year of life on average. E denotes early-life exposure group, no antibiotics for the past 2 years and >1 course per year of life on average. M6 denotes macrolide course within 6 months; M12 denotes macrolide course within 6–12 months; M24 denotes macrolide course within 12–24 months. P6, P12 and P24 denote penicillin courses within 6, 6–12 and 12–24 months, respectively. (a) Phyla composition. (b) Genus-level microbiota composition according to PCoA analysis. The background colour indicates interpolated time since the last macrolide course.CC BY · PubMed Central
Figure 2 Microbiota richness and maturity relative to age in the different groups. (a) Number of species-like phylotypes. (b) Score based on 24 age-associated genera (Supplementary Table 2). Asterisks indicate significance of the difference to the control group ‘C'. *P<0.05, **P<0.01 and ***P<0.001, estimated using linear models. Mean values are shown and the error bars show the s.e. values. The number of samples in both panels is 257 (Supplementary Table 1).
Figure 2 Microbiota richness and maturity relative to age in the different groups. (a) Number of species-like phylotypes. (b) Score based on 24 age-associated genera (Supplementary Table 2). Asterisks indicate significance of the difference to the control group ‘C'. *P<0.05, **P<0.01 and ***P<0.001, estimated using linear models. Mean values are shown and the error bars show the s.e. values. The number of samples in both panels is 257 (Supplementary Table 1).CC BY · PubMed Central
Figure 3 Macrolide resistance and bile-salt hydrolase abundance in relation to time since the last macrolide course. The dashed lines show the model fit (linear or polynomial), R2 indicates the variation explained by the model and the P values (estimated using linear models) are indicated. (a) Macrolide resistance potential inferred from metagenomic analysis, N=14. (b) Bile-salt hydrolase abundance in metagenomes, N=14. (c) Macrolide resistance measured as proportion of anaerobic c.f.u.'s growing with erythromycin compared with c.f.u. without erythromycin, N=80. (d) Combined relative abundance of three bile-salt hydrolase genes (bsh) based on qPCR as a function of time since last macrolide course, N=37.
Figure 3 Macrolide resistance and bile-salt hydrolase abundance in relation to time since the last macrolide course. The dashed lines show the model fit (linear or polynomial), R2 indicates the variation explained by the model and the P values (estimated using linear models) are indicated. (a) Macrolide resistance potential inferred from metagenomic analysis, N=14. (b) Bile-salt hydrolase abundance in metagenomes, N=14. (c) Macrolide resistance measured as proportion of anaerobic c.f.u.'s growing with erythromycin compared with c.f.u. without erythromycin, N=80. (d) Combined relative abundance of three bile-salt hydrolase genes (bsh) based on qPCR as a function of time since last macrolide course, N=37.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 63 references

Cited by

Metadata

Authors
Korpela, K., Salonen, A., Virta, L. J., Kekkonen, R. A., Forslund, K., Bork, P., & de Vos, W. M.
Affiliations
  • University of Helsinki (FI)
  • Social Insurance Institution (FI)
  • Valio (Finland) (FI)
Venue
Nature Communications
Published
2016-01-26
Volume
7
Issue
1
Pages
10410-10410
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2265709988
Cited by
698
References
64
Citations by year
2026: 38 · 2025: 52 · 2024: 54 · 2023: 62 · 2022: 73 · 2021: 71 · 2020: 93 · 2019: 71 · 2018: 77 · 2017: 72 · 2016: 34
FWCI
43.99
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (acceptedVersion)
  • Socio-Environmental Systems Modeling (acceptedVersion, cc-by)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Työväentutkimus Vuosikirja (submittedVersion, other-oa)
  • Data Archiving and Networked Services (DANS) (submittedVersion, cc-by)
Funders
  • Alexander von Humboldt-Stiftung
  • Academy of Finland (137389, 141140, 1272870)
  • FP7 Ideas: European Research Council (250172)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
  • Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
Keywords
gut microbiota, early-life antibiotic exposure, macrolides, penicillin, preschool children, asthma risk, bile salt hydrolase, macrolide resistance, actinobacteria, Bacteroidetes, Proteobacteria, microbiota composition, antibiotic prescribing
MeSH terms
Gastrointestinal Microbiome, Anti-Bacterial Agents, Bacteria, Bacterial Infections, Child, Child, Preschool, Day Care, Medical, Feces, Female, Finland, Humans, Male, Cohort Studies, Macrolides

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.